LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Next earnings ≈ Aug 5, 2026 · est. from filing cadence
Last earnings -3.9% on 2026-05-06
$5.39▼ -22.33%
over 1Y
L $3.66EODHDH $8.82
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W-2.7%
1M+12.3%
3M+39.3%
YTD-30.4%
1Y-22.3%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Unprofitable (net margin -30.0%).
LIFECORE BIOMEDICAL, INC. \DE\ shows $129M in FY2025 revenue (+0.5% YoY), a -30.0% net margin, and -2898.0% ROE.
Sources: SEC EDGAR (CIK 0001005286, latest 10-Q filed 2026-05-06) · as of 6/26/2026, 6:37:06 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.